Stephen, As you have said, "The much too little legitimate research into CS is due to 'scientific' and 'official' scepticism. And this is due to the lack of consistent [even minimal] quality of commercial products that have opportunistically capitalized on the small body of legitimate research that does exist...." This last bit doesn't sound right to me. Haven't others here been consistently saying that the folks who make the drugs have too much invested in the conventional anti biotics to see something like CS succeed? As simplistic as it may sound, these companies would be throwing away $Billions annually because people can buy CS inexpensively. Why do you blame this on current producers? Surely this problem goes back to 1938 and before. Reid
-- The silver-list is a moderated forum for discussion of colloidal silver. To join or quit silver-list or silver-digest send an e-mail message to: [email protected] -or- [email protected] with the word subscribe or unsubscribe in the SUBJECT line. To post, address your message to: [email protected] Silver-list archive: http://escribe.com/health/thesilverlist/index.html List maintainer: Mike Devour <[email protected]>

